Volume No. :   10

Issue No. :  2

Year :  2018

ISSN Print :  0975-234X

ISSN Online :  0975-4377


Registration

Allready Registrered
Click to Login

Formulation and Evaluation of Prolong Release Tablet of Anti-hypertensive Drug



Address:   Pradip Choudhari*
HSBPVT’s College of Pharmacy, Kashti
*Corresponding Author
DOI No: 10.5958/0975-4377.2018.00010.1

ABSTRACT:
Formulation of Prolonged release dosage form has a slower absorption rate than immediate release formulation and shows minimal fluctuation in plasma levels during steady state dosing interval. Additionally, the Once-daily dosage regimen has better patient compliance. Prolonged release tablet of Anti-hypertensive drug with Eudragit RS 30 D using wet granulation method yielded optimum results and process parameters like granulation spray rate and compression machine rotor speed was found robust product development. Stability studies showed that the formulation was stable after being kept at condition of 40° C±2°C/75% RH, for period of 3 months. The formulated product gave a dissolution profile similar to that of the innovator product (f2 value>80).
KEYWORDS:
Prolonged release dosage form, plasma levels, Eudragit RS, Stability studies, f2 value.
Cite:
Pradip Choudhari. Formulation and Evaluation of Prolong Release Tablet of Anti-hypertensive Drug. Res. J. Pharma. Dosage Forms and Tech.2018; 10(2): 55-59.
[View HTML]     



Visitor's No. :   109525